✦ LIBER ✦

Tumor M2 pyruvate kinase – determination in breast cancer patients receiving trastuzumab therapy

✍ Scribed by Markus Hoopmann; Mathias Warm; Peter Mallmann; Anke Thomas; Uwe-Jochen Göhring; Thomas Schöndorf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases in metastatic breast ca

✍ Javier Puente Vázquez; Sara López-Tarruella Cobo; José A. García-Sáenz; Antonio 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 379 KB

Tumor M2-pyruvate kinase in the follow-u

✍ Joachim Schneider; Kathleen Neu; Hans-Georg Velcovsky; Harald Morr; Erich Eigenb 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Trastuzumab-based neoadjuvant therapy in

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Optimal Duration of Cardiac Monitoring i

✍ Chiu, K.; Dubey, S.; Bull, D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Prognostic value of plasmatic tumor M2 p

✍ Fatela-Cantillo, Daniel; Fernandez-Suarez, Antonio; Moreno, Miguel Alonso Marin; 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 196 KB

Determination of pyruvate kinase type tu

✍ Z., Varga ;A., Hegele ;T., Stief ;A., Heidenreich ;R., Hofmann 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 93 KB